MIR3168

Across TCGA pan-cancer cohorts, MIR3168 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR3168 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MIR3168 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3168 expression acts as an unfavorable survival marker, although some lineages such as STAD and PCPG show a favorable association.

UVM, DLBC, and SKCM are the cancer types where MIR3168 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	III,IV	0.112	0.706	<.001	90	view →
DLBC	DFS	Tertile	II,III,IV	0.079	0.844	<.001	27	view →
SKCM	DFS	Tertile	III,IV	0.343	0.622	.011	24	view →
THYM	OS	Tertile	IV	0.294	1.000	.025	18	view →
STAD	OS	Tertile	IV	0.835	0.303	.047	9	view →
PCPG	DFS	Tertile	All	1.000	0.718	.031	9	view →
LUAD	DFS	Tertile	II,III,IV	0.762	0.391	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR3168–UVM (DFS)

Open the UVM breakdown →